City of Hope Announces New Hematologic Malignancies and Stem Cell ...
A world leader in the treatment of blood cancers, City of Hope is now launching an institute specifically focused on understanding and treating people with lymphoma, leukemia and myeloma, as well as other serious blood and bone marrow diseases. Through ...
Business Wire (press release) - Mon, 27 Oct 2014 08:45

Fate Therapeutics to Present at Nomura Biotechnology Conference
The Company has built two adult stem cell modulation platforms: a hematopoietic stem cell (HSC) modulation platform, which seeks to optimize the therapeutic potential of HSCs for treating patients with hematologic malignancies and rare genetic ...
MarketWatch - Thu, 30 Oct 2014 04:03



Double-unit cord-blood transplantation does not aid survival in children with ...
In children with hematologic malignancy, there was no significant difference in terms of 1-year survival between single- and double-unit cord-blood transplantation groups. 2. Children who received double-unit cord-blood transplantation were more likely ...
2 Minute Medicine - Wed, 29 Oct 2014 15:41

Double-unit cord-blood transplant failed to extend survival in blood cancers
Healio - Wed, 29 Oct 2014 14:00

An A/C germline single-nucleotide polymorphism in the TNFAIP3 gene is ...
Prior studies identified genetic variations of the TNFAIP3 gene (tumor necrosis factor, alpha-induced protein 3) as risk alleles for multiple autoimmune diseases.22, 23, 24, 25, 26, 27, 28 The cytoplasmic protein A20 is encoded by the TNFAIP3 gene. A20 ...
Nature.com - Thu, 30 Oct 2014 00:14

Cord Blood Transplant: In Children, One Will Do
"We found that among children and adolescents with hematologic cancer, survival rates were similar after single-unit and double-unit cord-blood transplantation," concluded principal and corresponding author John E. Wagner, MD, a pediatric hematologist ...
Medscape - Wed, 29 Oct 2014 14:09

BloodCenter of Wisconsin announces availability of cancer mutation HemeOnc ...
The NGS panel developed by BloodCenter of Wisconsin is designed to detect variants in 30 genes that are either prognostic or diagnostic for 10 different myeloid hematologic malignancies. Genetic profiling of hematologic malignancies through NGS is ...
News-Medical.net - Thu, 30 Oct 2014 04:48



Two Shotgun Injuries, One Lead-Protection Case
Hydroxyurea therapy is commonly used to treat both malignant and nonmalignant hematologic disorders, they wrote. The authors reported that the side effects that the patient presented were a well-known reaction. "The complex of histologic changes ...
MedPage Today - Thu, 30 Oct 2014 06:41



Anti-TNF Treatment: Cancer and Infections
Treatment with tumor necrosis factor (TNF) inhibiting agents among patients with rheumatoid arthritis (RA) was associated with decreased rates of malignancy, but patients with various autoimmune diseases receiving anti-TNF therapy had a greater ... The ...
MedPage Today - Wed, 29 Oct 2014 08:11


1  2  3  4  5  6  7  8    ->


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014